Similarly, PARP inhibitors can sensitize cells to ionizing radiation even in glioma stem cells, which can promote resistance to radiation by overexpressing PARP (254, 255), because the radiation generates single-strain DNA to exert clinical effect (256). Here, PARP1 is linked to central nervous system cancer.